Stroke Research and Treatment

metrics 2024

Connecting global researchers to combat stroke challenges.

Introduction

Stroke Research and Treatment is a premier Open Access journal published by HINDAWI LTD, dedicated to advancing the understanding and management of stroke and related neurological disorders. Since its inception in 2010, this journal has established itself as a valuable resource for researchers and clinicians in the field of neurology, providing a platform for high-quality, peer-reviewed articles that aim to improve patient outcomes and stimulate clinical practice innovations. With a 2023 Scopus ranking placing it in the Q3 category and a percentile ranking of 44th in clinical neurology, the journal is positioned to influence the ongoing discourse in stroke research. Stroke Research and Treatment embraces a global audience, with its editorial operations based in London, England. The journal's commitment to open access ensures that its content is freely available to all, promoting extensive dissemination and engagement in this critical field of study. Researchers, professionals, and students are encouraged to contribute their findings to this dynamic journal, fostering collaboration and knowledge sharing in the ongoing fight against stroke.

Metrics 2024

SCIMAGO Journal Rank0.59
Journal Impact Factor1.80
Journal Impact Factor (5 years)4.40
H-Index43
Journal IF Without Self1.80
Eigen Factor0.00
Normal Eigen Factor0.16
Influence1.10
Immediacy Index0.70
Cited Half Life7.90
Citing Half Life9.00
JCI0.35
Total Documents357
WOS Total Citations875
SCIMAGO Total Citations2600
SCIMAGO SELF Citations28
Scopus Journal Rank0.59
Cites / Document (2 Years)1.80
Cites / Document (3 Years)2.12
Cites / Document (4 Years)2.10

Metrics History

Rank 2024

Scopus

Neurology (clinical) in Medicine
Rank #221/400
Percentile 44.75
Quartile Q3

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 62/96
Percentile 35.90
Quartile Q3

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 72/96
Percentile 25.00
Quartile Q4

Quartile History

Similar Journals

Archives of Neuroscience

Championing academic excellence in neuroscience exploration.
Publisher: BRIEFLANDISSN: 2322-3944Frequency: 4 issues/year

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

Translational Stroke Research

Connecting the dots between neuroscience and stroke recovery.
Publisher: SPRINGERISSN: 1868-4483Frequency: 6 issues/year

Translational Stroke Research, published by Springer, stands at the forefront of the intersection of cardiology, neurology, and neuroscience, specifically focusing on the latest advancements in stroke research from 2010 to 2024. With an impressive impact factor as evidenced by its Q1 rankings in Cardiology and Cardiovascular Medicine, Clinical Neurology, and Neuroscience, this journal is a vital resource for researchers, clinicians, and students alike. It holds significant recognition in the academic community, achieving notable rankings in Scopus, including 15th out of 387 in Cardiology and 17th out of 400 in Clinical Neurology, showcasing its impact and relevance in these critical fields. Although not an open-access journal, it provides access options through institutional subscriptions, thereby facilitating the sharing of influential research that has the potential to shape the mitigation and understanding of stroke and related conditions. Researchers and practitioners seeking to expand their knowledge and engage with cutting-edge findings will find Translational Stroke Research to be an indispensable addition to their scholarly resources.

Topics in Stroke Rehabilitation

Connecting theory to practice in stroke care.
Publisher: TAYLOR & FRANCIS LTDISSN: 1074-9357Frequency: 6 issues/year

Topics in Stroke Rehabilitation, published by Taylor & Francis Ltd, stands as a premier academic journal offering cutting-edge research and insights in the fields of rehabilitation, neurology, and community care. With an impressive impact factor reflecting its strong scholarly influence, this journal not only maintains a distinguished Q1 ranking in Community and Home Care and Rehabilitation but is also recognized in the Q2 category for Clinical Neurology, showcasing its relevance across multiple disciplines. Covering a comprehensive range of topics from neurorehabilitation techniques to patient-centered care strategies, Topics in Stroke Rehabilitation serves as an essential resource for researchers, healthcare professionals, and students dedicated to enhancing the quality of life for individuals recovering from stroke. With an accessible archive dating back to 1996 and continuous publication through 2024, this journal invites collaboration and discourse, fostering advancements in both theoretical knowledge and practical applications within the realm of stroke rehabilitation.

Seminars in Pediatric Neurology

Fostering collaboration between researchers and clinicians.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 1071-9091Frequency: 4 issues/year

Seminars in Pediatric Neurology, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the evolving field of pediatric neurological disorders. Since its inception in 1994, this peer-reviewed journal has provided critical insights and cutting-edge research to support healthcare professionals in enhancing the quality of care for children with neurological conditions. With an impressive 2023 impact factor and a Q2 ranking in both the clinical neurology and pediatrics categories, it stands as a vital resource, fostering the dissemination of knowledge among researchers and clinicians alike. Featuring articles that explore a range of topics from clinical trials to innovative treatment modalities, this journal empowers practitioners with the latest findings in pediatric neurology. While primarily subscription-based, it plays a key role in bridging the gap between academia and clinical practice, making it an indispensable tool for anyone involved in the care and treatment of pediatric neurological patients.

Annals of Clinical and Translational Neurology

Empowering Progress in Clinical Neuroscience
Publisher: WILEYISSN: 2328-9503Frequency: 12 issues/year

Annals of Clinical and Translational Neurology is a premier journal published by WILEY, focusing on the fields of neurology and neuroscience. Since its inception in 2014, it has established itself as an Open Access platform, providing unrestricted access to cutting-edge research to promote scientific collaboration and innovation. With an impressive Impact Factor residing in the top quartile (Q1) for both clinical neurology and miscellaneous neuroscience in 2023, this journal ranks #52 out of 400 in the Neurology category and #22 out of 113 in General Neuroscience, indicating its significant contribution to the field. The journal welcomes submissions that address emerging trends and challenges in translational neurology, aiming to bridge the gap between laboratory research and clinical practice. By disseminating high-quality research and fostering a community of scholars, Annals of Clinical and Translational Neurology plays a vital role in advancing our understanding of neurological disorders and improving patient care worldwide.

EUROPEAN NEUROLOGY

Connecting Researchers and Clinicians in Neurology
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

JOURNAL OF THE NEUROLOGICAL SCIENCES

Exploring breakthroughs in clinical and experimental neurology.
Publisher: ELSEVIERISSN: 0022-510XFrequency: 12 issues/year

JOURNAL OF THE NEUROLOGICAL SCIENCES, published by Elsevier, is a leading academic journal that has been at the forefront of neurology research since its inception in 1964. With a robust scope covering both clinical and experimental neurological sciences, this journal serves as an invaluable resource for researchers, practitioners, and students in the field. The journal is indexed with an impressive Q2 ranking in Neurology and a remarkable Q1 status in Clinical Neurology as of 2023, reflecting its high impact and relevance in the medical community. The journal's Scopus rankings further emphasize its significance, holding the 69th position in clinical neurology and 35th in neuroscience, marking it in the top 82nd percentile of its peers. While the journal operates under a traditional subscription model, it continues to offer a platform for groundbreaking research and comprehensive reviews that advance our understanding of neurological disorders. Researchers and clinicians alike will find the JOURNAL OF THE NEUROLOGICAL SCIENCES an essential contribution to the literature, paving the way for innovations in clinical practices and therapeutic strategies.

Cerebrovascular Diseases Extra

Unlocking Innovations in Cerebrovascular Research
Publisher: KARGERISSN: 1664-5456Frequency: 3 issues/year

Cerebrovascular Diseases Extra is a distinguished open-access journal published by KARGER, operating out of Switzerland since 2011. With ISSN 1664-5456, this journal aims to bridge the gap in knowledge surrounding cerebrovascular diseases, an essential segment of both Cardiology and Cardiovascular Medicine as well as Neurology. Ranked in the third quartile by Scopus for various categories, including Cardiology, Neurology, and Clinical Neurology, it is specially designed for academics, clinicians, and researchers who seek to disseminate and gain insights into the latest advancements and research findings in these critical areas. By embracing open access, it amplifies the reach and impact of its published research, ensuring that vital information is readily accessible to a global audience. As the journal converges towards its targeted years from 2015 to 2024, it remains a pivotal platform for fostering innovative ideas and collaborative research in cerebrovascular health.

Stroke-Vascular and Interventional Neurology

Driving excellence in the understanding of cerebrovascular diseases.
Publisher: WILEYISSN: 2694-5746Frequency: 6 issues/year

Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

Journal of Stroke & Cerebrovascular Diseases

Connecting Research with Clinical Excellence
Publisher: ELSEVIERISSN: 1052-3057Frequency: 12 issues/year

Journal of Stroke & Cerebrovascular Diseases, published by ELSEVIER, is a leading international peer-reviewed journal dedicated to advancing the research and understanding of stroke and cerebrovascular disorders. With an impressive impact factor reflective of its rigorous academic standards, this journal is indexed in the highest echelons of medical disciplines, boasting a Q1 classification in Rehabilitation and prominent rankings in related fields. Established in 1991 and converging its focus toward 2024, it serves as a vital resource for researchers and clinicians interested in the complexities and treatment of cerebrovascular conditions. The journal's broad scope spans essential categories such as cardiology, neurology, and surgery, making significant contributions that enhance clinical practices and patient outcomes. For researchers, professionals, and students alike, the Journal of Stroke & Cerebrovascular Diseases is not just a publication but a critical platform for sharing innovative findings and fostering impactful discussions within the medical community.